Steven Valiquette
Stock Analyst at Mizuho
(3.06)
# 1,262
Out of 4,869 analysts
109
Total ratings
62.96%
Success rate
5.32%
Average return
Main Sectors:
Stocks Rated by Steven Valiquette
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VEEV Veeva Systems | Maintains: Outperform | $280 → $295 | $280.08 | +5.33% | 3 | Jun 2, 2025 | |
| DOCS Doximity | Maintains: Neutral | $65 → $60 | $57.36 | +4.60% | 3 | May 16, 2025 | |
| ALGN Align Technology | Maintains: Outperform | $250 → $245 | $181.79 | +34.77% | 11 | Apr 29, 2025 | |
| MCK McKesson | Maintains: Neutral | $630 → $690 | $720.92 | -4.29% | 3 | Apr 3, 2025 | |
| CAH Cardinal Health | Maintains: Outperform | $142 → $150 | $163.40 | -8.20% | 6 | Mar 31, 2025 | |
| XRAY DENTSPLY SIRONA | Maintains: Neutral | $21 → $18 | $15.37 | +17.11% | 7 | Mar 13, 2025 | |
| SOLV Solventum | Maintains: Neutral | $70 → $82 | $73.57 | +11.46% | 2 | Mar 3, 2025 | |
| LFMD LifeMD | Initiates: Neutral | $7 | $14.76 | -52.57% | 1 | Dec 4, 2024 | |
| HQY HealthEquity | Initiates: Outperform | $126 | $101.30 | +24.38% | 1 | Dec 4, 2024 | |
| HSIC Henry Schein | Initiates: Neutral | $75 | $71.98 | +4.20% | 5 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $5 | $2.68 | +86.57% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Underperform | $20 | $18.89 | +5.88% | 1 | Dec 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $18 → $14 | $7.34 | +90.74% | 7 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $142 | $171.70 | -17.30% | 10 | Sep 21, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $55 | $62.45 | -11.93% | 6 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $82 → $92 | $151.24 | -39.17% | 10 | Aug 2, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $565 | $302.01 | +87.08% | 5 | Apr 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $110 → $100 | $66.57 | +50.22% | 1 | Mar 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $17 → $14 | $4.44 | +215.32% | 1 | Feb 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $380 → $400 | $294.01 | +36.05% | 4 | Oct 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Overweight | $107 | $54.40 | +96.69% | 1 | Jul 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Equal-Weight | $22 → $17 | $30.05 | -43.43% | 3 | Apr 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $5 → $12 | $6.82 | +75.95% | 1 | Jun 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Overweight | $96 | $119.18 | -19.45% | 3 | Nov 23, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Neutral | $105 → $120 | $179.43 | -33.12% | 6 | Apr 30, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $117 → $127 | $377.50 | -66.36% | 1 | Apr 22, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $327 → $358 | $239.62 | +49.40% | 3 | Dec 6, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Equal-Weight | $78 → $60 | $11.31 | +430.50% | 3 | Apr 3, 2019 |
Veeva Systems
Jun 2, 2025
Maintains: Outperform
Price Target: $280 → $295
Current: $280.08
Upside: +5.33%
Doximity
May 16, 2025
Maintains: Neutral
Price Target: $65 → $60
Current: $57.36
Upside: +4.60%
Align Technology
Apr 29, 2025
Maintains: Outperform
Price Target: $250 → $245
Current: $181.79
Upside: +34.77%
McKesson
Apr 3, 2025
Maintains: Neutral
Price Target: $630 → $690
Current: $720.92
Upside: -4.29%
Cardinal Health
Mar 31, 2025
Maintains: Outperform
Price Target: $142 → $150
Current: $163.40
Upside: -8.20%
DENTSPLY SIRONA
Mar 13, 2025
Maintains: Neutral
Price Target: $21 → $18
Current: $15.37
Upside: +17.11%
Solventum
Mar 3, 2025
Maintains: Neutral
Price Target: $70 → $82
Current: $73.57
Upside: +11.46%
LifeMD
Dec 4, 2024
Initiates: Neutral
Price Target: $7
Current: $14.76
Upside: -52.57%
HealthEquity
Dec 4, 2024
Initiates: Outperform
Price Target: $126
Current: $101.30
Upside: +24.38%
Henry Schein
Dec 4, 2024
Initiates: Neutral
Price Target: $75
Current: $71.98
Upside: +4.20%
Dec 4, 2024
Initiates: Outperform
Price Target: $5
Current: $2.68
Upside: +86.57%
Dec 4, 2024
Initiates: Underperform
Price Target: $20
Current: $18.89
Upside: +5.88%
Nov 5, 2024
Maintains: Equal-Weight
Price Target: $18 → $14
Current: $7.34
Upside: +90.74%
Sep 21, 2023
Maintains: Equal-Weight
Price Target: $142
Current: $171.70
Upside: -17.30%
Aug 4, 2023
Maintains: Overweight
Price Target: $55
Current: $62.45
Upside: -11.93%
Aug 2, 2023
Maintains: Overweight
Price Target: $82 → $92
Current: $151.24
Upside: -39.17%
Apr 14, 2023
Maintains: Overweight
Price Target: $565
Current: $302.01
Upside: +87.08%
Mar 30, 2023
Maintains: Overweight
Price Target: $110 → $100
Current: $66.57
Upside: +50.22%
Feb 27, 2023
Maintains: Overweight
Price Target: $17 → $14
Current: $4.44
Upside: +215.32%
Oct 28, 2022
Maintains: Overweight
Price Target: $380 → $400
Current: $294.01
Upside: +36.05%
Jul 28, 2022
Reinstates: Overweight
Price Target: $107
Current: $54.40
Upside: +96.69%
Apr 18, 2022
Downgrades: Equal-Weight
Price Target: $22 → $17
Current: $30.05
Upside: -43.43%
Jun 11, 2021
Upgrades: Overweight
Price Target: $5 → $12
Current: $6.82
Upside: +75.95%
Nov 23, 2020
Upgrades: Overweight
Price Target: $96
Current: $119.18
Upside: -19.45%
Apr 30, 2020
Reiterates: Neutral
Price Target: $105 → $120
Current: $179.43
Upside: -33.12%
Apr 22, 2020
Maintains: Overweight
Price Target: $117 → $127
Current: $377.50
Upside: -66.36%
Dec 6, 2019
Maintains: Overweight
Price Target: $327 → $358
Current: $239.62
Upside: +49.40%
Apr 3, 2019
Maintains: Equal-Weight
Price Target: $78 → $60
Current: $11.31
Upside: +430.50%